Concentrations of sRAGE in serum and follicular fluid in assisted reproductive cycles - A preliminary study

Clinical Laboratory

Volumn 56, Issue 9-10, 2010, Pages 377-384

  Maličková, Karin ^a   Jarošová, Radka ^a   Řežábek, Karel ^a   Fait, Tomáš ^a   Mašata, Jaromir ^a   Janatková, Ivana ^a   Zima, Tomáš ^a   Kalousová, Marta ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Follicular fluid; In vitro fertilisation; Oocyte; Pregnancy; Soluble receptor for advanced glycation end products (sRAGE)

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCT; UNCLASSIFIED DRUG; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ADULT; ARTICLE; BLOOD DONOR; BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE STERILITY; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; MALE STERILITY; OVARY CYCLE; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; OVARY INFLAMMATION; OVULATION; PREGNANCY RATE; TREATMENT OUTCOME; BLOOD; FERTILIZATION; INFLAMMATION; METABOLISM; OVARY FOLLICLE; OVULATION INDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PREGNANCY; REFERENCE VALUE;

MAMMALIA;

ADULT; BLOOD DONORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; FOLLICULAR FLUID; HUMANS; INFLAMMATION; OVARIAN FOLLICLE; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; RECEPTORS, IMMUNOLOGIC; REFERENCE VALUES;

EID: 79952112942     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Buscher U, Chen FC, Kentenich H, Schmiady H. Cytokines in the follicular fluid of stimulated and non-stimulated human ovaries; is ovulation a suppressed inflammatory reaction? Hum Reprod 1999;14(1):162-6.
2. Gerard, N, Caillaud M, Martoriati A, Goudet G, Lalmanach AC. The interleukin-1 system and female reproduction. J Endocrinol 2004;180(2):203-12.
3. Karström-Encrantz L, Runesson E, Boström EK, Brännström M. Selective presence of the chemokine growth-regulated oncogene alpha (GROalpha) in the human follicle and secretion from cultured granulosa-lutein cells at ovulation. Mol Hum Reprod 1998;4(11):1077-83. (Pubitemid 28509000)
4. Orvieto R, Chen R, Ashkenazi J, Ben-Haroush A, Bar J, Fisch B. C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle. Hum Reprod 2004; 19 (2):357-9. (Pubitemid 38220006)
5. Yanagi K, Makinoda S, Fujii R, et al. Cyclic changes of granulocyte colony-stimulating factor (G-CSF) mRNA in the human follicle during the normal menstrual cycle and immunolocalization of G-CSF protein. Hum Reprod 2002;17(12):3046-52.
6. Bierhaus A, Humpert PM, Morcos M, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005;83(11):876-86. (Pubitemid 41598688)
7. Santilli F, Vazzana N, Bucciarelli LG, Davi G. Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr Med Chem 2009;16(8):940-52.
8. Ramasamy R, Yan SF, Schmidt AM. RAGE: therapeutic target and biomarker of the inflammatory response - the evidence mounts. J Leukoc Biol, 2009;86(3):505-12. Epub 2009 May 28.
9. Geroldi D, Falcone C, Emanuele E. Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target. Curr Med Chem 2006;13(17):1971-8.
10. Kalousová M, Jáchymová M, Mestek O, et al. Receptor for advanced glycation end products - soluble form and gene polymorphisms in chronic haemodialysis patients. Nephrol Dial Transplant 2007;22(7):2020-6. (Pubitemid 47244776)
11. Kalousová M, Bartosová K, Zima T, Skibová J, Teplan V, Viklický O. Pregnancy-associated plasma protein a and soluble receptor for advanced glycation end products after kidney transplantation. Kidney Blood Press Res 2007;30(1):31-7.
12. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis 2008;196(1):9-21.
13. Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 2005;7(4):R817-24.
14. Buhimschi IA, Zhao G, Pettker CM, et al. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation. Am J Obstet Gynecol 2007;196(2):181-3.
15. Romero R, Espinoza J, Hassan S, et al. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation. J Perinat Med 2008;36(5):p388-98.
16. Pertyńska-Marczewska M, Głowacka E, Sobczak M, Cypryk K, Wilczyński J. Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and nondiabetic pregnancies. Am J Reprod Immunol 2009;61(2):175-82.
17. Fujii EY, Nakayama M, Nakagawa A. Concentrations of receptor for advanced glycation end products, VEGF and CML in plasma, follicular fluid, and peritoneal fluid in women with and without endometriosis. Reprod Sci 2008;15(10):1066-74.
18. Fujii EY, Nakayama M. The measurements of RAGE, VEGF, and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging. Fertil Steril 2009;10.1016/j.fertnstert.2009.03.029.
19. Hájek Z, Germanová A, Koucký M, et al. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study. J Perinat Med 2008;36(5):399-404.
20. Orvieto R, Chen R, Ashkenazi J, Ben-Haroush A, Bar J, Fisch B. C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle. Hum Reprod 2004; 19(2):357-9. (Pubitemid 38220006)